Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel E Gilchrist

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Fundamental & Clinical Pharmacology|August 26, 2009
Lactation stage-dependent expression of transporters in rat whole mammary gland and primary mammary epithelial organoidsSamuel E Gilchrist, Jane Alcorn
International Journal of Pharmaceutics|November 22, 2011
The solid-state characterization of fusidic acidSamuel E Gilchrist, Kevin Letchford, Helen M Burt
Clinical Pharmacokinetics|March 13, 2013
A review of the pharmacokinetic implications of schistosomiasisKyle J Wilby, Samuel E Gilchrist, Mary H H Ensom
Journal of Materials Science. Materials in Medicine|April 25, 2012
The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibioticsMichelle Chakraborti, John K Jackson, David Plackett, et al.
Molecular Pharmaceutics|April 10, 2012
Phase separation behavior of fusidic acid and rifampicin in PLGA microspheresSamuel E Gilchrist, Deborah L Rickard, Kevin Letchford, et al.
The Annals of Pharmacotherapy|April 4, 2013
Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic reviewCelia L Culley, Tony K L Kiang, Samuel E Gilchrist, et al.
The Annals of Pharmacotherapy|March 13, 2012
Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malariaKyle J Wilby, Tim T Y Lau, Samuel E Gilchrist, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2013
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infectionsSamuel E Gilchrist, Dirk Lange, Kevin Letchford, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Fundamental & Clinical Pharmacology|August 26, 2009
Lactation stage-dependent expression of transporters in rat whole mammary gland and primary mammary epithelial organoidsSamuel E Gilchrist, Jane Alcorn
International Journal of Pharmaceutics|November 22, 2011
The solid-state characterization of fusidic acidSamuel E Gilchrist, Kevin Letchford, Helen M Burt
Clinical Pharmacokinetics|March 13, 2013
A review of the pharmacokinetic implications of schistosomiasisKyle J Wilby, Samuel E Gilchrist, Mary H H Ensom
Journal of Materials Science. Materials in Medicine|April 25, 2012
The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibioticsMichelle Chakraborti, John K Jackson, David Plackett, et al.
Molecular Pharmaceutics|April 10, 2012
Phase separation behavior of fusidic acid and rifampicin in PLGA microspheresSamuel E Gilchrist, Deborah L Rickard, Kevin Letchford, et al.
The Annals of Pharmacotherapy|April 4, 2013
Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic reviewCelia L Culley, Tony K L Kiang, Samuel E Gilchrist, et al.
The Annals of Pharmacotherapy|March 13, 2012
Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malariaKyle J Wilby, Tim T Y Lau, Samuel E Gilchrist, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2013
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infectionsSamuel E Gilchrist, Dirk Lange, Kevin Letchford, et al.
Pageof 1